| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/1994 | CA2114712A1 Substituted phenyl sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
| 08/09/1994 | US5336785 Method for preparation of taxol |
| 08/09/1994 | US5336783 Calpain inhibitor cystamidin A and its production |
| 08/09/1994 | US5336781 Aminating sulfonated indole derivatives |
| 08/09/1994 | US5336778 Substituted triazoles as angiotensin II antagonists |
| 08/09/1994 | US5336771 Certain 3,4-dihydro-2H-pyrano[2,3-b]pyridines |
| 08/09/1994 | US5336770 Reacting guanosine and 2-oxa-1,4-butanediol diacetate in the presence of an acid catalyst and acid anhydride followed by ester hydrolysis to produce acyclovir |
| 08/09/1994 | US5336769 Xanthine derivatives |
| 08/09/1994 | US5336767 Total or partial esters of hyaluronic acid |
| 08/09/1994 | US5336764 Reverse transcriptase inhibitor; HIV viricides; AIDS therapy |
| 08/09/1994 | US5336759 Biologically active peptide derived from frog (frog CNP) |
| 08/09/1994 | US5336691 Composition comprising a tramadol material and acetaminophen and its use |
| 08/09/1994 | US5336690 Anticholesterol agents |
| 08/09/1994 | US5336689 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 08/09/1994 | US5336688 Composition containing organogermanium compound and immunity adjusting agents comprising the compositions |
| 08/09/1994 | US5336686 17 Methylene lactones of steroids |
| 08/09/1994 | US5336685 Use of flavonoids to treat multidrug resistant cancer cells |
| 08/09/1994 | US5336684 Oxidation products of cephalomannine |
| 08/09/1994 | US5336680 Smoking suppressant and method of application thereof |
| 08/09/1994 | US5336678 Topical administration |
| 08/09/1994 | US5336677 Substituted aminopyrimidines as antihypertensives |
| 08/09/1994 | US5336676 [3H,7H]thiazolo[3,4-a]pyridines with antiasthmatic and antiinflammatory actions on the respiratory tract |
| 08/09/1994 | US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans |
| 08/09/1994 | US5336674 2-phenanthridinyl carbaphenem antibacterial agent |
| 08/09/1994 | US5336673 3-substituted cephem compounds |
| 08/09/1994 | US5336672 Increasing egg production in poultry |
| 08/09/1994 | US5336669 Mixture with hydrate which has been melted, precipitated, refrozen and redried, crystal structure, water solubility |
| 08/09/1994 | US5336620 Process for the production of an anticoagulant composition |
| 08/09/1994 | US5336504 Sustained release drug delivery by administering pellets with core of diltiazem and organic acid mixture surrounded by multilayered membrane containing blends of both water soluble and insoluble synthetic polymers |
| 08/09/1994 | US5336503 Administering a myosin light chaing kinase inhibitor |
| 08/09/1994 | US5336500 For disinfection of hard surfaces |
| 08/09/1994 | US5336496 Inhibitor for delta 5-desaturase |
| 08/09/1994 | US5336487 Low intraocular emulsification; specific gravity just greater than water; push back and maintain in place an inferior retina |
| 08/09/1994 | US5336486 Administering polycarbophil by mouth in amount to suppress appetite without inducing laxative effect |
| 08/09/1994 | US5336485 Administering cholestane phthalates, succinates or sulfates before administering tacrine |
| 08/09/1994 | CA1331382C 5-nitrobenzo [de] isoquinoline-1.3-diones, their preparation and their use |
| 08/09/1994 | CA1331381C Antibacterial agents - ii |
| 08/09/1994 | CA1331345C Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth |
| 08/09/1994 | CA1331341C Covered retard forms |
| 08/09/1994 | CA1331333C Antimicrobial antifoam compositions and methods |
| 08/06/1994 | CA2115016A1 Derivatives of 2-(4-4-azolylbutyl)-1-piperazinyl-5-hydroxy pyrimidine, their preparation and their application as medications |
| 08/06/1994 | CA2113913A1 Acetanilide derivatives |
| 08/04/1994 | WO1994017123A1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug |
| 08/04/1994 | WO1994017108A1 Anticoagulant composition |
| 08/04/1994 | WO1994017094A1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
| 08/04/1994 | WO1994017093A1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
| 08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
| 08/04/1994 | WO1994017090A1 2,6-diaminopurine derivatives |
| 08/04/1994 | WO1994017085A1 Desalaninebenanomicin a derivative and production thereof |
| 08/04/1994 | WO1994017076A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 08/04/1994 | WO1994017074A1 Process for the manufacture of a tricyclic compound |
| 08/04/1994 | WO1994017071A1 Tricyclic heterocyclic compounds as 5-ht4 receptor antagonists |
| 08/04/1994 | WO1994017066A1 2-phenanthridinyl carbapenem antibacterial agents |
| 08/04/1994 | WO1994017065A1 2-phenanthridinyl carbapenem antibacterial agents |
| 08/04/1994 | WO1994017063A1 N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE 4H-IMIDAZO[4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS |
| 08/04/1994 | WO1994017061A1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 08/04/1994 | WO1994017055A1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 08/04/1994 | WO1994017054A1 Oxime derivatives |
| 08/04/1994 | WO1994017052A1 C2 taxane derivatives and pharmaceutical compositions containing them |
| 08/04/1994 | WO1994017051A1 Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 08/04/1994 | WO1994017050A1 C7 taxane derivatives and pharmaceutical compositions containing them |
| 08/04/1994 | WO1994017045A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 08/04/1994 | WO1994017040A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 08/04/1994 | WO1994017038A1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 08/04/1994 | WO1994017035A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
| 08/04/1994 | WO1994017034A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
| 08/04/1994 | WO1994017016A1 Deuterated sevoflurane as an inhalational anesthetic |
| 08/04/1994 | WO1994016740A1 The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016736A1 Localization of therapeutic agents |
| 08/04/1994 | WO1994016731A1 Ganglioside-klh conjugate vaccines with qs-21 |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | WO1994016719A1 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016715A1 Selective cell proliferation |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016712A1 Creatine phosphate, creatine phosphate analogs, and uses therefor |
| 08/04/1994 | WO1994016711A1 Prevention and treatment of myocardial failure |
| 08/04/1994 | WO1994016710A1 Topical ketoconazole compositions |
| 08/04/1994 | WO1994016709A2 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 08/04/1994 | WO1994016708A1 Pharmaceutical composition for treating nicotine dependence |
| 08/04/1994 | WO1994016707A1 Transdermal therapeutic system with galanthamine as active ingredient |
| 08/04/1994 | WO1994016706A1 Therapeutic inhibitors of vascular smooth muscle cells |
| 08/04/1994 | WO1994016705A2 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| 08/04/1994 | WO1994016704A1 Oxime-substituted therapeutic compounds |
| 08/04/1994 | WO1994016703A1 Ciclobenzaprine-caffeine combination as a muscle relaxant |
| 08/04/1994 | WO1994016701A1 Methods and compositions of (2s,4r) itraconazole for treating fungal yeast and dermatophyte infections |
| 08/04/1994 | WO1994016700A1 Method and composition employing (2r,4s) itraconazole |
| 08/04/1994 | WO1994016699A1 Compositions containing tandospirone or its analogs |
| 08/04/1994 | WO1994016698A1 Medicaments having central analgesic activity |
| 08/04/1994 | WO1994016697A1 Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 08/04/1994 | WO1994016696A1 Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
| 08/04/1994 | WO1994016695A1 Pharmaceutical compositions containing cimetidine |
| 08/04/1994 | WO1994016694A1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 08/04/1994 | WO1994016693A1 Stable oral ci-981 formulation and process of preparing same |
| 08/04/1994 | WO1994016692A1 Method and compositions for treating anoestrus |
| 08/04/1994 | WO1994016691A1 Nitroglycerine-containing plaster, process for producing the same and its use |
| 08/04/1994 | WO1994016690A1 Method for increasing the efficiency of feed conversion in animals |
| 08/04/1994 | WO1994016689A1 Analgesic medicinal composition |